Search this site:
LANDMARK STUDY DEMONSTRATES LOWER RATE OF INAPPROPRIATE SHOCKS IN PATIENTS WITH SORIN DUAL CHAMBER ICD DEVICES
Late-Breaking data presented at Heart Rhythm Society’s 2013 Annual Meeting show ...
SORIN GROUP ANNOUNCES FDA APPROVAL AND U.S. LAUNCH OF SMARTVIEW (tm) REMOTE MONITORING SOLUTION FOR PATIENTS WITH IMPLANTED CARDIAC DEFIBRILLATORS
Denver, May 10
2013 – Sorin Group, (Reuters Code: SORN.MI), a global medical ...
SORIN S.P.A. STOCKHOLDERS’ MEETING APPROVES 2012 FINANCIAL RESULTS AND APPOINTS BOARD OF STATUTORY AUDITORS
Milan, April 30, 2013 – At a meeting held today and chaired by Rosario Bifulco, the Sorin ...
In the Spotlight
Sorin Group is pleased to announce the acquisition of CalMed Labs, Inc.
With the recent addition of a minimally invasive cannulae line and now the acquisition of ...
Landmark Study Demonstrates Lower Rate Of Inappropriate Shocks In Patients With...
Late-Breaking data presented at Heart Rhythm Society’s 2013 Annual Meeting show benefits ...
Sorin Group Receives Conditional FDA Approval To Conduct Ide Clinical Trial For...
Primary objective of the prospective, non randomized trial is to demonstrate the safety and ...
Cardiac Rhythm Management
Working at Sorin
Check for jobs